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ABSTRACT
￿
Plasminogen activators are highly selective proteases that activate the proenzyme
plasminogen to the general protease, plasmin .We studied a porcine kidney cell line, originally
isolated as a high producer of plasminogen activator, in which activities of cellular adenylate
cyclase and CAMP-dependent protein kinase are increased in response to calcitonin . We found
that salmon calcitonin, in the concentration range 0.03-300 nM, increased plasminogen
activator production up to
￿
1,000-fold and concurrently inhibited cell multiplication ; both of
these effects were reversible . Human calcitonin was -0.01 times as potent as salmon calcitonin,
corresponding to potency differences observed in other biological systems . Plasminogen
activator production was also stimulated by other agents that raise cellular CAMP levels such
as cholera toxin, phosphodiesterase inhibitors, and vasopressin, but not to the same extent as
by calcitonins . The rapidity and sensitivity of the plasminogen activator determination and
other cellular responses may make it possible in the future to use this cell strain in a convenient
bioassay for calcitonins and their analogues .
Calcitonins stimulate adenylate cyclase activity in bone and
kidney . These hormones act to decrease bone resorption and
renal transport of calcium, sodium, magnesium, and inorganic
phosphate (5, 16) . We have found that a cultured cell line
derived from porcine kidney (LLC-PK,) responds to calciton-
ins and vasopressin with an increase in cellular CAMP content
(8, 11) and activation of CAMP-dependent protein kinase (1) .
These cells had originally been isolated by Hull et al . (12) as a
potential source for plasminogen activator, an enzyme whose
secretion in other cell cultures is modulated by several hor-
mones, including some whose effects are normally mediated
by CAMP . It therefore appeared interesting to determine
whether calcitonins and vasopressin could affect enzyme pro-
duction in the porcine renal tubular cells as well.
In this report we show that calcitonins can markedly stimu-
late plasminogen activator production by LLC-PK I cells and,
in addition, inhibit their replication . Other agents that increase
CAMP levels in these cells also increase release of plasminogen
activator, although a direct correlation ofCAMP with plasmin-
ogen activator levels has not been established .
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MATERIALS AND METHODS
Hormone Solutions and Other Reagents
Test solutions ofsalmon calcitonin were prepared from lyophilized samples of
syntheticsalmon calcitonin that weresupplied by Dr.H.T.Keutmann (Endocrine
Unit, Massachusetts General Hospital, Boston, Mass.). Salmon calcitonin was
dissolved in 0.001 N acetic acid and used after dilution without sterilization . For
some experiments, salmon calcitonin was obtained from commercial sources
(Calcimar, Armour Pharmaceutical Co ., Phoenix, Ariz. ; 5,000 MRC U/mg) .
Synthetic human calcitonin (Cibacalcin) was a gift ofCiba-Geigy A . G., Basel,
Switzerland. The antidiuretic hormone wasa preparation ofarginine vasopressin
grade Vl (Sigma Chemical Co., St . Louis, Mo. 3671U/mg) . Cholera enterotoxin
was obtained from Becton, Dickinson, and Co., Orangeburg, N. Y . Phorbol
myristate acetate (Consolidated Midland, Brewster, N. Y .) was diluted from a
stock solution in absolute ethanol. 3-isobutyl-l-methylxanthine (IBMX) was
obtained from Aldrich Chemical Co ., Milwaukee, Wis . Dexamethasone, adeno-
sine-3'-5'-cyclic-monophosphoric acid, crystalline (CAMP),N602'-dibutyryladen-
osine-3'-5'-cyclic monophosphoric acid (dcAMP), and actinomycinDwere from
Sigma Chemical Co . All chemicals were the best commercial grades available .
Cell Culture
The LLC-PK, cell strain was originally isolated in 1958 and had been
maintained in culture through at least 400 passages (12). During this work, cells
195were carried in l0-cm Diam Falcon tissue culture dishes (FalconPlastics,Oxnard,
Calif) using Dulbecco's modification of Eagle's medium (Gibco Laboratories,
Grand Island Biological Co., Grand Island, N . Y.) supplemented with 10% fetal
calf serum (FCS) from Microbiological Associates, Walkersville, Md., plus 100
U of penicillin and 100 1+g of streptomycin/ml (Gibco Laboratories) (DMEM,
10% FCS) . For passage, the cells were washed three times with calcium- and
magnesium-free phosphate-buffered saline (PBS)(Gibco Laboratories), dispersed
with 0.25% trypsin-EDTA (Gibco Laboratories) at 37°C for 10 min, and plated
at -5.0-1 x 108 cells per 10-cm dish . Cells reached a density of-1-2 x 10 7 cells
per dish within 5-7 d at 37°C, 95% air, 5% C02. At that stage the cells showed a
tendency to pile up and form the domes reported by Hull et al . (12) . For our
experiments the cells were transferred aftertrypsinization into 3-cm Diam Falcon
plastic tissue culture dishes at 0.1-10 x 105 cells per dish, depending upon the
experiment, 1-3 d before the test incubation. At the end ofthis period, media
were removed and the cells were washed once with PBS containing calcium and
magnesium (Gibco Laboratories) and the experimentalincubation was initiated.
Experimental Incubations
After the cells were washed, 1 ml of serum-free medium(DMEM containing
penicillin and streptomycin and 10 mM HEPES, pH 7 .4) and the compounds
being tested were added to each dish and the culturesincubatedat 37°C, 95% air,
5% C02 . At the times indicated for each experiment, the media were removed
and frozen at -20°C for subsequent assay. Cells were trypsinized and counted
using a hemocytometer or a Coulter counter model Z (Coulter Electronics, Inc.,
Hialeah, Fla.).
Plasminogen Activator Determination
Plasminogen activator activity in samples ofconditioned media or cell lysates
was measured as the plasminogen-dependent rate offibrinolysis using "'I-fibrin-
coated multiwell plates (20) . Plasminogen was purified from human plasma by
affinity chromatography using t.-lysine-substituted Sepharose (6). Dilutions were
made to contain the equivalent of0.001-5 pl ofthe undiluted sample which were
then added to 250 pl of 0.1 M Tris-HC], pH 8 .1, containing 8 ug/ml of
plasminogen. The assay mixtures were incubated for 1 and 3 h at 37°C and the
radioactivity of the solubilized "I-fibrin peptides determined. Results are ex-
pressed in Ploug units, as determined with reference to a standardpreparation of
urokinase (Uroknase Reference Standard, Leo Pharmaceutical Products, Belle-
rup, Denmark) . The molecular weight of the enzyme was determined by SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) as previously described (10),
except that casein (21) was used instead of fibrin in the indicator gel. All
experiments includedappropriate controlsforreagentsandmedia; the modulators
ofplasminogen activator production tested did not affect activity in the assays at
the concentrations used . Assays performed in the absence ofplasminogen did not
reveal plasminogen-independent proteolytic activity, under any of the experi-
mental conditions.
RESULTS
Dose-dependent Stimulation of Plasminogen
Activator Secretion by Calcitonins and
by Vasopressin
LLC-PK, cells produce substantial levels of plasminogen
activator (12) . When cultures of those cells were exposed to
synthetic salmon orhuman calcitonin, or vasopressin, the level
of plasminogen activator activity in the conditioned medium
rose markedly (Fig. 1) . The response was dose dependent : the
threshold for the effect of salmon calcitonin was below 0.29
nM; maximum stimulation occurred at -290 nm, resulting in
a 500- to 1,000-fold increase in secreted enzyme activity. The
human hormone was at least two orders of magnitude less
potent and the maximum effect achieved at 1 .45 uM was less
than that of salmon calcitonin at 290 nM . Plasminogen acti-
vator activity was also increased in cultures exposed to vaso-
pressin, but 10,000-fold higher concentrations than salmon
calcitonin and 100-fold higher concentrations than human
calcitonin were needed to produce comparable effects .
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FIGURE 1
￿
Effects of calcitonins and vasopressin on LLC-PK, cells .
Stimulation of plasminogen activator activity as a function of hor-
mone concentration . LLC-PK, cells were plated in 3-cm diam dishes
at 0 .5x 10 6 cells/dish in DMEM,10% FCS, 5 d before the experiment.
After 2 d, media were removed, cells were washed once with PBS,
and then incubated for 72 h under conditions indicated : DMEM
without serum (") ; salmon calcitonin (" ; human calcitonin (") ;
vasopressin (O) . At the end of the incubation, media were removed
and assayed for plasminogen activator activity .
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FIGURE 2
￿
Effects of calcitonin on stimulation of plasminogen acti-
vator production by LLC-PK, cells . LLC-PK, cells were plated in 3-
cm diam dishes at 0 .5 x 106 cells/dish in DMEM, 10% FCS, 2 d
before the experiment . Media were then removed, cells washed
once with PBS, and then incubated for various periods in the
absence (") or presence (/) of 290-nM salmon calcitonin . At the
times indicated, media were removed and assayed for plasminogen
activator activity. Values are means t SEM for three dishes .Time-Course of Cálcitonin Effects
The time-course of the effects of maximally stimulatory
concentrations (290 nM) of salmon calcitonin on plasminogen
activator in culture media is shown in Fig . 2 . A substantial
increase of- 10-fold in extracellular plasminogen activator was
found at 4 h after addition ofhormone (not readily appreciated
because of the scale of Fig . 2). Although increases in plasmin-
ogen activator in this experiment were not strictly linear,
enzyme accumulation persisted for at least 48 h in the same
medium, although at progressively slower rates. Other experi-
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FIGURE 3
￿
Time-course of production of plasminogen activator by
LLC-PK, cells following previous exposure to salmon calcitonin .
Cells were plated 3 d before the experiment at 1 .0 x 10 6 cells/dish
in 2 ml DMEM, 10% FCS. Cells were then washed and incubated for
1 h either in 1 ml DMEM without serum (" ), or in DMEM plus
salmon calcitonin, 290 nM (/). After 1 h, cells were washed four
times with PBS and both sets of cells then incubated in DMEM
without serumandwithout calcitonin . At thetimes indicated, media
were removedandassayed forplasminogen activator activity . Values
are means t SEM for three dishes .
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TABLE I
Effect of Inhibitors ofRNA and Protein Synthesis on Plasminogen Activator Production
ments were performed in which cultures were exposed to
salmon calcitonin (290 nM) for only 1 h, washed, incubated
further and the conditioned media was analyzed for enzyme
activity. Under these conditions, significant increases in extra-
cellular plasminogen activator were observed in media sampled
20 min after removal of calcitonin (0.155 t 0.020 U/ml after
calcitonin preincubation, compared with 0.075 ± 0.005 U/ml
in cells not preincubated with calcitonin) . In other similar
experiments such as that illustrated in Fig. 3, the persistent
stimulatory effects of calcitonin were demonstrated in media
assayed from 2 to 28 h after removal of the hormone . An
increased rate of enzyme secretion was observed up to 8 h after
removal ofthe hormone and then appeared to reach a plateau .
Hence the effects of salmon calcitonin, although slowly revers-
ible, were long-lasting, and once initiated, did not dissipate
immediately on removal of hormone from the medium .
The increase in medium plasminogen activator activity in-
duced by calcitonin required genetic transcription and trans-
lation as shown by the inhibitory effects of cycloheximide and
actinomycin (Table I) . At the concentration of the inhibitors
utilized in these experiments, the stimulatory effect of calci-
tonin was markedly suppressed (by 97% with cycloheximide
and by 93% with actinomycin D) but nevertheless still apparent.
Furthermore, in the absence of inhibitors, total plasminogen
TABLE II
Effect of Salmon Calcitonin on Cell-associated and Cell-
secreted Plasminogen Activator
Plasminogen Activa-
tor (1-1/culture)
Condi
Cell tioned
lysate medium
Control cultures
￿
2.2
￿
1 .2
Salmon calcitonin-treated cultures
￿
100
￿
896
Confluent cultures were washed and placed in DMEM withoutserum in the
absence or presence of 290nM salmon calcitonin . After 24 h themedium was
collected, and the cells were washed four times with PBS, before scraping
into 0.2% Triton X-100 for plasminogen activator assay, and the total plasmin-
ogen activator in the cells and the media calculated .
Cells were plated in 3-cm Diam dishes at 0.5 x 108 cells/dish, 3 d before the experiment, in DMEM, 10% FCS. After 3d cells were washed once with PBS and
preincubated for 1 h in 1 ml DMEM (without serum) alone, with 5hg/ml cycloheximide, or 5 gg/ml actinomycin D. After 1 h, media were removed and the cells
washed twice with PBS . Each of the three sets of cell culture dishes were then distributed into two subgroups with or without salmon calcitonin plus the
corresponding inhibitors for 24 h (1 ml/dish) . Triplicate dishes were used for cell number and plasminogen activator activity . Values for cell number are means
t SEM for three dishes.
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Culture conditions Culture time
h
Plasminogen
activator
U/Ml
Number of cells
(x 10 -6 )
No hormone 2 0.04 2.5 t 0.1
No inhibitor 24 0.03 2.9 t 0.2
Salmon calcitonin, 290 nM 2 8 2.4 t 0.3
24 77 2.0t0.2
No hormone 2 0 2.4-L0.1
Cycloheximide (5lyg/ml) 24 0.02 2.1 ± 0.3
Salmon calcitonin, 290 nM 2 0.05 2.4 t 0.2
24 2 2.2 t 0.6
No hormone 2 0.03 2.5 t 0.2
Actinomycin D (5 gg/ml) 24 0.19 1 .5 ± 0.5
Salmon calcitonin, 290 nM 2 0.15 2.4 t 0.2
24 6 1 .0 t 0.7activator activity in the cultures was increased in the presence
of salmon calcitonin (Table II); both the cell-associated and
the secreted enzyme levels were markedly higher in the hor-
mone-treated cultures . Hence, the stimulatory effects of the
hormone on increasing plasminogen activator in culture media
are dependent upon formation of active enzyme ; probably
through increased synthesis. In this respect, this cell system
resembles others in all of which hormonal modulation of
plasminogen activator production is dependent upon the main-
tenance ofRNA and protein synthesis (19, 20) .
Effects of Other Agnets on Induction of
Plasminogen ActivatorSynthesis
Because calcitonin and vasopressin are known to stimulate
adenylate cyclase in these and in other cells, it was important
to test other agents that influence CAMP metabolism for their
ability to increase medium plasminogen activator activity . As
seen in Table III, although added cAMP itself was ineffective,
the cAMP-phosphodiesterase inhibitor IBMX stimulated plas-
minogen activator synthesis, and the effects of cAMP and
IBMX were synergistic . Levels of enzyme activity in themedia
from cells incubated with both CAMP and IBMX were only
slightly lower than the maximum achieved in this experiment
with salmon calcitonin . Cholera toxin, which activates adenyl-
ate cyclase in most cells, also stimulated plasminogenactivator
production but only to the extent produced by exposure to
IBMX alone .
Glucocorticoids and the tumor promoter phorbol myristate
acetate (PMA) modulate plasminogen activator production in
a variety of cell types ; the former usually inhibits whereas the
latter usually stimulates enzyme synthesis (21) . In LLC-PK 1
cells, the glucocorticoid, dexamethasone, decreased both spon-
taneous and calcitonin-stimulated plasminogen activator pro-
duction (Table III) . In five separate experiments the magnitude
of this inhibitory effect tended to be variable, ranging from
20% to 900 10, although we have, so far, not succeeded in
identifying the basis of this variability.
Similar variability was observed in the effects of PMA. At
TABLE III
Modulation of Plasminogen Activator Production
Plas-
mino-
A .
B.
calcitonin (290 nM)
Cells were plated in 3-cm Diam dishes each containing 0.8 x 108 cells (A) or
0.4X108 cells ( 8) in DMEM,10% FC5, 1 d before each experiment. After 1 d,
media were removed, cells washed once with PBS, and then incubated in 1
ml DMEM without serum under indicated conditions for an additional 24 h .
At the end of the incubation, media were removed and assayed for plasmin-
ogen activator activity . Values for cell number are means f SEM for three
dishes .
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FIGURE 4 SIDS-polyacrylamide gel electrophoresis of conditioned
medium and cell lysate from salmon calcitonin-treated cultures of
LLC-PK, cells . An aliquot (1 ,al) of conditioned medium, lanes A1
and 131, or of cell lysate (2 ftl), lanes A2 and 82, each containing 0.2
U plasminogen activator, were electrophoresed in an 11% polyacryl-
amide slab gel containing SDS. Theelectrophoretic gel wasanalyzed
for plasminogen activator activity by placing it over a casein/agar
indicator gel in the presence (panel A) or absence (panel 8) of 40
1Lg/ml human plasminogen . The indicator gel was photographed
(using dark-field illumination) after 3 h of incubation at 37°C. Zones
of proteolysis appear dark on a light gray background .
concentrations ranging from 1 ng to 1 wg/ml, PMA always
stimulated plasminogen activator production . Although the
degree of stimulation varied from 5- to 50-fold, it was always
belowthe maximumproduced by stimulation of the cells with
salmon calcitonin.
Characterization of Plasminogen Activator
Produced by LLC-PK1 Cells
To identify the species of plasminogen activator produced
by LLC-PK I cells, aliquots of conditioned medium and cell
extracts from basal and calcitonin-stimulated cultures were
analyzed by a zymographic method based on SDS-PAGE
(109) . As seen in Fig . 4, there were two major bands of
plasminogen activator activity that migrated with apparent
molecularweightsof 50,000 and 29,000, respectively. These
results are consistent with the values for molecular weight of
plasminogen activator species previously purified from these
cells (3) . The major band (50,000 mol wt) coincided in its
migration with the major cell culture and urinaryplasminogen
activatorofrats, mice,and hamsters,whoseapparent molecular
weights are somewhat lower than that of human urokinase .
The enzyme species in media from unstimulated cultures were
indistinguishable with respect to their electrophoretic mobility
from those from calcitonin-treated cultures (data not shown) .
Inhibition of Cell Multiplication by Calcitonin
In addition to the effects of calcitonin on plasminogen
activator production, we also observed that calcitonin inhibited
proliferation of the LLC-PK I cells (Tables I and III) . These
effects were further studied in experiments such as those illus-
trated in Fig . 5, where it canbe seen that the concentration of
salmon calcitonin that produced 50% inhibition of cell repli-
cation was ^-2.9 nM : complete inhibition ofcell replication was
observed at concentrations of 29 nM and greater . The lower
Culture conditions
gen ac-
tivator
U/ml
Number of
cells
x 10 -e
No addition 6 2.29 t 0.04
IBMX (1 mM) 40 2.35 ± 0.07
cAMP (1 mM) 2 2.59 t 0.02
cAMP (1 mM) + IBMX (1 mM) 226 2.20 t 0.02
Cholera toxin (10 ng/ml) 39 2 .15 t 0.01
Salmon calcitonin (290 nM) 375 1.18 t 0.03
No addition 1 1.21 t 0.07
Dexamethasone (50 nM) 0.1 1 .43t 0.04
Salmon calcitonin (290 nM) 130 0.43 ± 0.05
Dexamethasone (50 nM) + salmon 28 0.51 t 0.03DISCUSSION
-" No Addition
" Salmon Coldtonin
* Human Coldtonin
o Vosopressin
nM
FIGURE 5
￿
Effects of calcitonins and vasopressin on proliferation of
LLC-PK, cells . Conditions were as in Fig . 1 . DMEM without serum
(" ) ; salmon calcitonin (/) ; human calcitonin (") ; vasopressin (O).
Values are means ± SEM for three dishes .
potency ofhuman calcitonin in stimulating plasminogen acti-
vator synthesis was correlated with corresponding decreases in
its effect on cell replication . Although, in the experiment
described in Fig . 5, a small, barely significant inhibition of cell
replication was found with the highest concentration of vaso-
pressin (2,000 nM), no consistent inhibition of cell replication
by vasopressin was found in several other experiments (not
shown) . It can also be seen in Table III that IBMX with or
without CAMP or cholera toxin, which increased plasminogen
activator synthesis, had no significant effects on replication of
the LLC-PK, cells .
Our results show that salmon calcitonin stimulated plasmino-
gen activator production in a porcine renal tubular cell strain.
Human calcitonin had similar effects but only at concentrations
greater than two orders of magnitude higher than those of the
salmon hormone . With respect to salmon calcitonin, it is clear
that detectable stimulation occurred even at -0.03-0.3 nM and
that the cellular response was observed at hormone concentra-
tions that correspond to the binding of radioactive hormone to
putative receptors in membrane preparations (13) . The plas-
minogen activator response in cell culture also reflected the
relative potencies of different calcitonins observed in intact
animals, namely more than two orders of magnitude higher
potency of salmon compared with human calcitonin . Because
plasminogen activator activity can be determined rapidly and
conveniently with material obtained from small numbers of
cells, the stimulation of plasminogen activator production in
LLC-PK, cultures suggests itselfas a favorable bioassay system
both for calcitonins and for agents that may modulate calci-
tonin action . The potential attractiveness of this bioassay can
be appreciated by comparison with the in vivo systems cur-
rently available for calcitonin : these are based on changes in
plasma calcium levels, require numerous animals, large
amounts of hormone, and the range of the measured response
is far smaller than that described here (up to 1,000-fold) . The
monitoring of plasminogen activator production as a cell cul-
ture bioassay for polypeptide hormones has already been illus-
trated using ovarian granulosa cells (2) . At this time, however,
the specificity of the calcitonin effects in the LLC-PK, cells
has not been investigated sufficiently.
Of several other hormones tested, only vasopressin produced
a measureable increase in plasminogen activator production as
well as an increase in cellular content of cAMP in these cells.
The concentration ofvasopressin required for threshold effects
on plasminogen activator was -30 nM (-100- to 1000-fold
that of salmon calcitonin) and even at 2 jtM, vasopressin
stimulation was only ^"2-4% that of salmon calcitonin . How-
ever, vasopressin, at concentrations equal to those ofcalcitonin,
increased cAMP content acutely in the LLC-PK, cells to an
extent similar to that of salmon calcitonin (8, 11) . We do not
know why the observed potency differences between salmon
calcitonin and vasopressin are so large if the mechanisms of
their effects on plasminogen activator production are mediated
entirely through changes in cellular cAMP content .
In comparing the effects of vasopressin and calcitonin on
plasminogen activator in the renal tubular cells and relating
them to changes in concentrations of cAMP, one must take
into account the kinetics ofthese changes . For example, in our
initial report (8) we showed that in the absence of phosphodi-
esterase inhibitors, equivalent concentrations (2.9 nM) of
salmon calcitonin and arginine vasopressin produced a similar
increase (fourfold) in the CAMP content after 10 min . These
levels were markedly increased in the presence ofIBMX . We
also found that the content of CAMP in the cells exposed to
either hormone in the absence of IBMX did not remain ele-
vated but returned to base line by 24 h . Despite the fact that
the CAMP contents were similar in cells exposed briefly to
either hormone, activation of adenylate cyclase persists in cells
exposed to calcitonin but not in cells exposed to vasopressin
(11). The persistence of adenylate cyclase activation in cells
preincubated with salmon calcitonin could be measured by
exposing the cells to IBMX alone .
The long-term effects ofcAMP in the presence of IBMX or
cholera toxin alone, described here, of stimulation of plasmin-
ogen activator synthesis, nevertheless suggest that enzyme in-
duction by salmon calcitonin could be mediated at least in part
by hormonal activation of adenylate cyclase . In several other
experiments (not shown) attempts to incubate cells for long
periods, in the absence of serum, with IBMX in addition to
hormones or cholera toxin, were associated with cell toxicity,
and were therefore difficult to interpret. It is also possible that
effects of calcitonins other than those responsible for changes
inCAMP content could explain the marked effects on plasmin-
ogen activator. For example, because calcitonins in vivo alter
renal transport of several ions such as calcium and sodium (5,
16), it is conceivable that altered ion fluxes in these cells could
influence specific protein synthesis . To begin to explore this
possibility, in preliminary studies, we have observed significant
inhibition of calcitonin-stimulated plasminogen activator pro-
duction in LLC-PK, cells by 10 [.M ouabain . [ 3H]Ouabain
binds to sites on the plasmalemma of these cells which corre-
sponds to basolateral membranes of other cells (15) . This
binding is presumably to the Na+-K+-ATPase, an accepted
marker for, if not the actual "sodium pump."
Inhibition of cell replication was a second facet ofcalcitonin
action observed in these cultures . The extent of growth inhi-
bition as a function of salmon calcitonin concentration was
generally parallel with the dose-response curve for plasminogen
activator induction, whereas the low potency of human calci-
tonin and vasopressin as inducers of enzyme synthesis was
associated with relatively feeble or negligible effects on growth.
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substances on cell growth has been proposed (7, 9, 17, 22) . The
observations that vasopressin or agents that increase cellular
cAMP such as cholera toxin and exogenous cAMP in the
presence ofIBMX did not inhibit replication of the LLC-PK I
cells, cannot be offered as proof that salmon Calcitonin inhi-
bition is not mediated byCAMP, because experiments have not
yet been performed to compare the kinetics or duration of
action of the different compounds .
It is of interest to consider which physiologic or pharmaco-
logic aspects of the action of these hormones in vivo, if any,
may be correlated with the induction ofplasminogen activator
synthesis . For example, it is established that injections oflarge
amounts of vasopressin shorten human euglobulin lysis time
(4), an effect subject to tachyphylaxis. This suggests the possi-
bility that our observations of the responses in cell culture
could reflect some action of these hormones in vivo, at least
when administered in pharmacologic doses . In support of this
possibility are observations that salmon Calcitonin administered
to humans in amounts used to treat Paget's disease of bone
acutely increase urinary plasminogen activity (14) . An addi-
tional consideration is that effects of hormones such as Calci-
tonin could be modulated in a target tissue (kidney) by secre-
tion of a protease such as plasminogen activator and by acti-
vation of extracellular plasminogen . The protease generated
could be involved in the processing or degradation of that
hormone, or other protein substrates. Investigations of such
possiblities are targets for future efforts.
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